NCT06126432 is a NA clinical trial of Yugart in Precancerous Lesions, sponsored by National Cheng-Kung University Hospital.

Who is sponsoring NCT06126432?

NCT06126432 is sponsored by National Cheng-Kung University Hospital.

What drugs are being tested in NCT06126432?

Interventions in NCT06126432: Yugart.

What condition does NCT06126432 study?

NCT06126432 studies Precancerous Lesions.

Is NCT06126432 still recruiting?

NCT06126432 is currently completed. Last updated 13 November 2023.

Last reviewed 2023-11-13 · How we verify

NCT06126432

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Beneficial Effects of Probiotics on Improvement of Gut Dysbiosis and Ascending Cholangitis in Patients Received Pancreaticoduodenectomy

Completed NA Last updated 13 November 2023

What this trial tests

NA trial testing Yugart in Precancerous Lesions in 20 participants. Completed in 31 July 2019.

Timeline

30 March 2015

Primary endpoint
31 December 2018

31 July 2019

Quick facts

Lead sponsor	National Cheng-Kung University Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	20
Start date	30 March 2015
Primary completion	31 December 2018
Estimated completion	31 July 2019
Sites	1 location across Taiwan

Drugs / interventions tested

Yugart

Conditions studied

Precancerous Lesions — all drugs for Precancerous Lesions →

Sponsor

National Cheng-Kung University Hospital

Who can join

Adults 18 to 120, any sex, with Precancerous Lesions. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To determine whether probiotics have beneficial effect on gut dysbiosis and postoperative ascending cholangitis in patients with pancreaticoduodenectomy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Precancerous Lesions

Currently open trials in the same condition.

NCT07040020 — This Randomized, Single-center Trial Aims to Evaluate the Advantages of Underwater ESD (U-ESD) in Comparison to the Conv · NA · recruiting

Other National Cheng-Kung University Hospital trials

Trials by the same sponsor.

NCT07525713 — Virtual Reality Mirror Therapy With Focused Object-Directed Attention System · NA · not yet recruiting
NCT07369271 — Continuous Cervical Erector Spinae Plane Block Versus Interscalene Nerve Block in Shoulder Arthroscopic Surgery · NA · not yet recruiting
NCT07262411 — Peer-based Recovery Program · NA · not yet recruiting
NCT07257926 — Prevention of Delayed Post-polypectomy Bleeding by Endoscopic Sucralfate Spray in High-risk Patients: A Randomized Contr · Phase 4 · not yet recruiting
NCT07269132 — Applying the ADDIE Model to Develop a Multimedia Program to Enhance Chemotherapy Knowledge and Self-Efficacy Among Inten · NA · enrolling by invitation

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06126432 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by National Cheng-Kung University Hospital
Last refreshed: 13 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06126432.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing